KR890011974A - 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도 - Google Patents

산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도 Download PDF

Info

Publication number
KR890011974A
KR890011974A KR1019890000932A KR890000932A KR890011974A KR 890011974 A KR890011974 A KR 890011974A KR 1019890000932 A KR1019890000932 A KR 1019890000932A KR 890000932 A KR890000932 A KR 890000932A KR 890011974 A KR890011974 A KR 890011974A
Authority
KR
South Korea
Prior art keywords
oxidation
vitamin
mixture according
sensitive compounds
sensitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019890000932A
Other languages
English (en)
Korean (ko)
Inventor
찌하루 후카마찌
슈마커 호스트
베베르트 볼프강
슈나이더 요아힘
Original Assignee
후가와 히데아끼
니신 바디쉐 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후가와 히데아끼, 니신 바디쉐 가부시끼가이샤 filed Critical 후가와 히데아끼
Publication of KR890011974A publication Critical patent/KR890011974A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019890000932A 1988-01-29 1989-01-28 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도 Ceased KR890011974A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1723288 1988-01-29
JP63-17232 1988-01-29

Publications (1)

Publication Number Publication Date
KR890011974A true KR890011974A (ko) 1989-08-23

Family

ID=11938201

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000932A Ceased KR890011974A (ko) 1988-01-29 1989-01-28 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도

Country Status (10)

Country Link
US (1) US4929774A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0326026B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR890011974A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1023229C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1331136C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE58901641D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK174663B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL88961A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN171845B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1639425A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
JPH02124894A (ja) * 1988-11-01 1990-05-14 Sanwa Kagaku Kenkyusho Co Ltd フィチン酸安定化組成物
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
EP1714640A1 (en) * 1992-07-13 2006-10-25 Shiseido Company, Ltd. Stabilised external skin treatment composition comprising retinol.
US5270063A (en) * 1992-08-03 1993-12-14 Kellogg Company Ready-to-eat cereal products enriched with beta-carotene
FR2703263B1 (fr) * 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH07203950A (ja) * 1994-01-26 1995-08-08 Kanegafuchi Chem Ind Co Ltd 被覆されたファフィア・ロドチーマ酵母及びその造粒物
AUPM677594A0 (en) * 1994-07-12 1994-08-04 Daratech Pty Ltd Preservation of exposed underground plant structures
NZ306211A (en) * 1995-04-07 1998-08-26 Abbott Lab Calcium supplements, in particular beverage concentrates, with vitamin d and a calcium source
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
DE19518845A1 (de) * 1995-05-23 1996-11-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure
US5827904A (en) * 1996-09-27 1998-10-27 Hahn; David Medical implant composition
AU752468B2 (en) 1997-04-04 2002-09-19 Phyllis E. Bowen Lutein esters having high bioavailability
US6007856A (en) * 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
ES2228467T3 (es) 1999-02-03 2005-04-16 Biosante Pharmaceuticals, Inc. Particulas terapeuticas de fosfato calcico y metodos de fabricacion y su uso.
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
EP1355877A1 (en) * 2001-01-30 2003-10-29 Sabinsa Corporation Process of obtaining compositions of stable lutein and lutein derivatives
WO2006073503A1 (en) * 2001-02-27 2006-07-13 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
KR101277367B1 (ko) 2003-01-31 2013-06-20 디에스엠 아이피 어셋츠 비.브이. 카로티노이드를 포함하는 조성물
DE10311585A1 (de) 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
DE10325989A1 (de) * 2003-06-07 2005-01-05 Glatt Gmbh Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
US7446101B1 (en) * 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
BRPI0509148B8 (pt) 2004-03-22 2021-05-25 Abbott Products Gmbh composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina contendo tensoativos, seus usos e respectivos processos de fabricação
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
WO2006011592A1 (ja) * 2004-07-30 2006-02-02 Wakunaga Pharmaceutical Co., Ltd. カプセル皮膜用組成物、カプセル皮膜、及びこれを用いたカプセル剤
CA2586035A1 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
RU2290173C2 (ru) * 2005-04-04 2006-12-27 Открытое акционерное общество "Научно-исследовательский институт технологий медицинской промышленности" (ОАО"НИИ ТМП") Способ получения стабильных сухих порошков жирорастворимых витаминов или каротиноидов
HUE034739T2 (en) 2005-07-29 2018-02-28 Abbott Laboratories Gmbh Reduced viral pancreatin
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US7767238B2 (en) * 2005-11-04 2010-08-03 Pepsico, Inc. Beverage composition and method of preventing degradation of vitamins in beverages
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
JP6954917B2 (ja) * 2016-03-24 2021-10-27 ビーエイエスエフ・ソシエタス・エウロパエアＢａｓｆ Ｓｅ 多相活性物質調製物
WO2024173923A2 (en) * 2023-02-17 2024-08-22 Solugen, Inc. Feed compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen

Also Published As

Publication number Publication date
IN171845B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-01-23
DK35589D0 (da) 1989-01-27
DK35589A (da) 1989-07-30
EP0326026A3 (en) 1990-11-14
IL88961A0 (en) 1989-08-15
CN1023229C (zh) 1993-12-22
DK174663B1 (da) 2003-08-18
CA1331136C (en) 1994-08-02
US4929774A (en) 1990-05-29
EP0326026A2 (de) 1989-08-02
DE58901641D1 (de) 1992-07-23
IL88961A (en) 1992-07-15
CN1036220A (zh) 1989-10-11
SU1639425A3 (ru) 1991-03-30
EP0326026B1 (de) 1992-06-17

Similar Documents

Publication Publication Date Title
KR890011974A (ko) 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도
JP4571736B2 (ja) 安定な粉末状のビタミンおよび／またはカロチノイド製品ならびにその製法
KR890012566A (ko) 두나리에라 조체함유 고형상 식품과 그 제조법
RU2008113843A (ru) Ферментный гранулят i, содержащий фитазу
GB1459740A (en) Cat food
CA2274467A1 (en) Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use
CA2034642A1 (en) A process for making simulated fruit pieces
EP0835613A3 (de) Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
US2470281A (en) Preservative coatings for foods
KR910009678B1 (ko) 진공포장 두나리에라(dunaliella)조체 함유식품의 제조방법
RU2003105240A (ru) Усовершенствованный способ твердого дражирования
US2508477A (en) Enriched foodstuffs
KR900017500A (ko) 스낵제품의 제조방법
NO964016L (no) Krydderblanding for frossenmat-industri
AU2290197A (en) Pufa coated solid carrier particles for foodstuff
DE3776348D1 (de) Verfahren zur herstellung von produkten mit kontrollierter freigabe fuer kaugummi.
KR890001461A (ko) 조미 조성물 및 그의 제조방법
JPS59225114A (ja) ビタミンの保護
CA2388169A1 (en) Phospholipid composition and use of same
JPS63164863A (ja) 被覆有機酸及び有機酸塩製剤の製造方法
EE200200468A (et) Meetod toiduainete maitsestamiseks ja toiduaine
EP0907411B1 (en) Method for the encapsulation of liquids
JPS5549313A (en) Vitamin pharmaceutical and its preparation
US3297806A (en) Method of protecting unstable materials
ES464337A1 (es) Un procedimiento para la preparacion de una premezcla de a- limento en particulas que contienen elementos minoritarios, pero esenciales, tales como una vacuna oral, una vitamina o un elemento traza.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890128

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19931220

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19890128

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19970523

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19970822

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19970523

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I